Literature DB >> 2036663

Guidelines for controlled trials of drugs in migraine. First edition. International Headache Society Committee on Clinical Trials in Migraine.

.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 2036663

Source DB:  PubMed          Journal:  Cephalalgia        ISSN： 0333-1024            Impact factor:   6.292


× No keyword cloud information.
  25 in total

Review 1.  Drug treatment of migraine in children: a comparative review.

Authors:  S Evers
Journal:  Paediatr Drugs       Date:  1999 Jan-Mar       Impact factor: 3.022

Review 2.  Prospective study designs in outcomes research: the case of migraine.

Authors:  Elizabeth A Rothermich; Meryl I Brod; Warren H Schonfeld; Clayton R Rowland; Baltazar Gomez-Mancilla
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 3.  Taking the negative view of current migraine treatments: the unmet needs.

Authors:  Peer Tfelt-Hansen; Jes Olesen
Journal:  CNS Drugs       Date:  2012-05-01       Impact factor: 5.749

Review 4.  Chronic daily headaches in children.

Authors:  Andrew D Hershey; Marielle A Kabbouche; Scott W Powers
Journal:  Curr Pain Headache Rep       Date:  2006-10

Review 5.  Medication overuse headache: a critical review of end points in recent follow-up studies.

Authors:  Knut Hagen; Rigmor Jensen; Magne Geir Bøe; Lars Jacob Stovner
Journal:  J Headache Pain       Date:  2010-05-16       Impact factor: 7.277

Review 6.  Almotriptan: a review of its use in migraine.

Authors:  Susan J Keam; Karen L Goa; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Behavioral factors in the placebo response.

Authors:  R E Weeks; E Newman
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

Review 8.  The COMET Handbook: version 1.0.

Authors:  Paula R Williamson; Douglas G Altman; Heather Bagley; Karen L Barnes; Jane M Blazeby; Sara T Brookes; Mike Clarke; Elizabeth Gargon; Sarah Gorst; Nicola Harman; Jamie J Kirkham; Angus McNair; Cecilia A C Prinsen; Jochen Schmitt; Caroline B Terwee; Bridget Young
Journal:  Trials       Date:  2017-06-20       Impact factor: 2.279

9.  Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate.

Authors:  Mansoureh Togha; Togha Mansoureh; Masoud Rahmat Jirde; Kiafar Nilavari; Hosein Ashrafian; Soodeh Razeghi; Leila Kohan
Journal:  J Headache Pain       Date:  2008-02-20       Impact factor: 7.277

10.  Optimizing prophylactic treatment of migraine: Subtypes and patient matching.

Authors:  Michel Dib
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.